results of a phase ii study of palbociclib in esophageal and gastric cancer
Published 6 years ago • 280 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
0:55
dr. karasic on palbociclib in esophageal and gastric cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
20:21
check-point inhibitors in esophageal and gastric cancer: when and for whom?
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
1:14
palbociclib shows promise for treatment of brain metastases harboring cdk alterations
-
1:13
the impact of age, comorbidity on postoperative outcomes in esophageal and gastric cancer
-
7:46
results from the phase 2 fast study of astellas’ investigational zolbetuximab
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
1:25
pd-1 and pd-l1 expression in esophageal and gastric cancer
-
4:13
phase i study of obp-301 for locally advanced esophageal cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
0:59
results of the metgastric study
-
8:07
phase 1/2 study results of liposomal irinotecan and folfox in pancreatic cancer
-
1:33
dr. matthew j. ellis on neoadjuvant palbociclib in primary breast cancer
-
2:53
positive results for palbociclib/cetuximab therapy in head and neck cancer
-
25:44
complete responders vs. partial or non-responders in esophageal cancer | 2022 evolution conference
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer